{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Vcf":["ftp://ftp.sra.ebi.ac.uk/vol1/analysis/ERZ162/ERZ16293917/mblSNPs2_CAM.vcf.gz","ftp://ftp.sra.ebi.ac.uk/vol1/analysis/ERZ162/ERZ16293918/mblSNPs2_BUD.vcf.gz"],"Other":["ftp://ftp.sra.ebi.ac.uk/vol1/analysis/ERZ162/ERZ16293917/mblSNPs2_CAM.vcf.csi","ftp://ftp.sra.ebi.ac.uk/vol1/analysis/ERZ162/ERZ16293918/mblSNPs2_BUD.vcf.csi"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Department of Internal Medicine and Hematology, Semmelweis University","European Bioinformatics Institute"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJEB60441"],"broker_name":["EBI"],"scientific_name":["Homo sapiens"],"tag":["xref:EuropePMC:PMC10084477"],"long_description":["Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups"],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"","description":"Role of the complement lectin pathway activation in COVID-19 disease severity","dates":{"last_updated":"2023-03-17","first_public":"2023-03-09"},"accession":"PRJEB60441","cross_references":{"taxon":["9606"]}}